Status:
COMPLETED
Effect of CPAP on Blood Pressure in Patients With Sleep Apnea and Refractory Hypertension
Lead Sponsor:
Corporacion Parc Tauli
Collaborating Sponsors:
Carlos III Health Institute
Conditions:
Obstructive Sleep Apnea
Refractory Arterial Hypertension
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
The purpose of this study is to determine the effects of CPAP treatment on blood pressure in patients with sleep apnea syndrome (SAS) and refractory arterial hypertension (RAH). Also, some of the mec...
Eligibility Criteria
Inclusion
- refractory arterial hypertension and sleep apnea with apnea-hypopnea index over 15
Exclusion
- excessive sleepiness
- professional drivers
- secondary arterial hypertension
Key Trial Info
Start Date :
December 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2016
Estimated Enrollment :
68 Patients enrolled
Trial Details
Trial ID
NCT00863135
Start Date
December 1 2008
End Date
July 1 2016
Last Update
February 9 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Corporacio Parc Tauli
Sabadell, Barcelona, Spain, 08208